Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Feb;204(2):134.e1-20.
doi: 10.1016/j.ajog.2010.11.038.

Nifedipine in the management of preterm labor: a systematic review and metaanalysis

Agustín Conde-Agudelo  1 , Roberto Romero, Juan Pedro Kusanovic
Affiliations
Meta-Analysis

Nifedipine in the management of preterm labor: a systematic review and metaanalysis

Agustín Conde-Agudelo et al. Am J Obstet Gynecol. 2011 Feb.

Abstract

Objective: To determine the efficacy and safety of nifedipine as a tocolytic agent in women with preterm labor.

Study design: A systematic review and metaanalysis of randomized controlled trials.

Results: Twenty-six trials (2179 women) were included. Nifedipine was associated with a significant reduction in the risk of delivery within 7 days of initiation of treatment and before 34 weeks' gestation, respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage, neonatal jaundice, and admission to the neonatal intensive care unit when compared with β₂-adrenergic-receptor agonists. There was no difference between nifedipine and magnesium sulfate in tocolytic efficacy. Nifedipine was associated with significantly fewer maternal adverse events than β₂-adrenergic-receptor agonists and magnesium sulfate. Maintenance nifedipine tocolysis was ineffective in prolonging gestation or improving neonatal outcomes when compared with placebo or no treatment.

Conclusion: Nifedipine is superior to β₂-adrenergic-receptor agonists and magnesium sulfate for tocolysis in women with preterm labor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study selection process
See this image and copyright information in PMC

Comment in

References

    1. Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88:31–8. - PMC - PubMed
    1. Heron M, Sutton PD, Xu J, Ventura SJ, Strobino DM, Guyer B. Annual summary of vital statistics: 2007. Pediatrics. 2010;125:4–15. - PubMed
    1. Raju TN. Epidemiology of late preterm (near-term) births. Clin Perinatol. 2006;33:751–63. - PubMed
    1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84. - PMC - PubMed
    1. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371:261–9. - PubMed

Publication types

MeSH terms